International Journal of Clinical Pharmacy

, Volume 34, Issue 2, pp 364–373 | Cite as

General practitioners’ perceptions of pharmacists’ new services in New Zealand

  • Ernieda Hatah
  • Rhiannon Braund
  • Stephen Duffull
  • June Tordoff
Research Article


Background In recent years, the pharmacy profession has moved towards more patient-oriented services. Some examples are medication review, screening and monitoring for disease, and prescribing. The new services are intended to be in close collaboration with general practitioners (GPs) yet little is known of how GPs in New Zealand perceive these new services. Objective To examine GPs’ perceptions of pharmacists’ new services. Setting Study was undertaken at GPs’ practices in two localities in New Zealand. Methods Qualitative, face to face, semi-structured interviews were undertaken of 18 GPs. The cohort included GPs with less/more than 20 years of practice, and GPs who had experience of working in localities where some patients had undergone a medication review (Medicines Use Review, MUR) by community pharmacists. GPs were asked to share their perceptions about pharmacists providing some new services. Data were thematically analysed with constant comparison using NVivo 8 software. Using a business strategic planning approach, themes were further analysed and interpreted as the services’ potential Strengths, Weaknesses, Opportunities and Threats (SWOTs). Main outcomes measure GPs’ perceptions of pharmacists’ new services. Results GPs were more supportive of pharmacists’ playing active roles in medication review and less supportive of pharmacists practising screening-monitoring and prescribing. Discussions Pharmacists’ knowledge and skills in medication use and the perceived benefits of the services to patients were considered the potential strengths of the services. Weaknesses centred around potential patient confusion and harm, conflict and irritation to GPs’ practice, and the potential to fragment patient-care. Opportunities were the possibilities of improving communication, and having a close collaboration and integration with GPs’ practice. Apparent threats were the GPs’ perceptions of a related, and not renumerated, increase in their workloads, and the perception of limited benefit to patients. Conclusion Pharmacists should exploit their own strengths and the potential opportunities for these services, and reduce any weaknesses and threats. A possible strategic plan should include increased effective communication, piloting services, and the integration of some services into medical practices.


Community pharmacy services General practitioners Perceptions Pharmacists New Zealand 



We would like to thank the GPs who took part in this study and the community pharmacists who helped us identify the GPs whose patients had undergone a MUR.


Funding for this study was provided by the School of Pharmacy, University of Otago.

Conflicts of interest

None to declare.


  1. 1.
    Pharmaceutical Services Negotiating Committee (PSNC). About community pharmacy. [cited 2011 4th August]; Available from:
  2. 2.
    Kohn LT, Corrigan JM, Donaldson MS. To err is human: building a safer health system. Washington, DC: National Academy Press; 2000.Google Scholar
  3. 3.
    Parlimentary Office of Sciene and Technology Postnote Number 248. Changing role of pharmacies. 2005 [cited 2011 4th August]; Available from:
  4. 4.
    Youssef S. Medicines use reviews. London: Pharmaceutical Press; 2010.Google Scholar
  5. 5.
    Clyne W, Blenkinsopp A, Seal R. A guide to medication review. 2008; Available from:
  6. 6.
    Roughead EE, Barratt JD, Ramsay E, Pratt N, Ryan P, Peck R, Killer G, Gilbert AL. The effectiveness of collaborative medicine reviews in delaying time to next hospitalization for patients with heart failure in the practice setting: results of a cohort study. Circ Heart Fail. 2009;2(5):424.PubMedCrossRefGoogle Scholar
  7. 7.
    Johnson CL, Nicholas A, Divine H, Perrier DG, Blumenschein K, Steinke DT. Outcomes from DiabetesCARE: a pharmacist-provided diabetes management service. J Am Pharm Assoc. 2008;48(6):722–30.CrossRefGoogle Scholar
  8. 8.
    Bunting BA, Smith BH, Sutherland SE. The Asheville project: clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia. J Am Pharm Assoc. 2008;48(1):23–31.CrossRefGoogle Scholar
  9. 9.
    Isetts BJ, Schondelmeyer SW, Artz MB, Lenarz LA. Clinical and economic outcomes of medication therapy management services: the Minnesota experience. J Am Pharm Assoc. 2008;48(2):203–11.CrossRefGoogle Scholar
  10. 10.
    Pharmacy Council of New Zealand. Consultation document: proposed pharmacist prescriber scope of practice. [cited 2011 4th August]; Available from:
  11. 11.
    National Prescribing Centre (NPC). Non-medical prescribing. [cited 2011 4th August]; Available from:
  12. 12.
    Department of Medicines Policy (WHO) and Standards and International Pharmaceutical Federation. Developing pharmacy practice, a focus on patient-care. 2006 [cited 2011 4th August]; Available from:
  13. 13.
    Pharmacy Council of New Zealand. Medicines management: Definition, levels, competence framework. 2006 [cited 2011 14th August]; Available from:
  14. 14.
    Lee E, Braund R, Tordoff J. Examining the first year of medicines use review services provided by pharmacist in New ZEaland:2008. N Z Med J. 2009;122(1293):26–35.Google Scholar
  15. 15.
    District Health Board New Zealand (DHBNZ). New Zealand National Pharmacy Services Framework. [cited Oct 2011; Available from:
  16. 16.
    Buckley P, Grime J, Blenkinsopp A. Factors enabling or inhibiting the implementation of pharmacist prescribing in secondary care. Int J Pharm Pract. 2008;Suppl 1:A7–A8.Google Scholar
  17. 17.
    Gilbert AL, Roughead EE, Beilby J, Mott K, Barratt JD. Collaborative medication management services: improving patient care. Med J Aust. 2002;177(4):189–92.PubMedGoogle Scholar
  18. 18.
    Edmunds J, Calnan MW. The reprofessionalisation of community pharmacy? An exploration of attitudes to extended roles for community pharmacists amongst pharmacists and general practitioners in the United Kingdom. Soc Sci Med. 2001;53:943–55.PubMedCrossRefGoogle Scholar
  19. 19.
    Van C, Krass I, Mitchell B. General practitioner perceptions of extended pharmacy services and modes of collaboration with pharmacists. J Pharm Pract Res. 2007;37(3):182–6.Google Scholar
  20. 20.
    Blenkinsopp A, Tann J, Evans A, Grime J. Opportunity or threat? General practitioner perceptions of pharmacist prescribing. Int J Pharm Pract. 2008;16(1):29–34.CrossRefGoogle Scholar
  21. 21.
    Ranelli P, Biss J. Physicians’ perceptions of communication with and responsibilities of pharmacists. J Am Pharm Assoc (Wash). 2000;40(5):625–30.Google Scholar
  22. 22.
    Alkhateeb FM, Clauson KA, McCafferty R, Latif DA. Physician attitudes toward pharmacist provision of medication therapy management services. Pharm World Sci. 2009;31(4):487–93.PubMedCrossRefGoogle Scholar
  23. 23.
    Zillich AJ, McDonough RP, Carter BL, Doucette WR. Influential characteristics of physician/pharmacist collaborative relationships. Ann Pharmacother. 2004;38:764–70.PubMedCrossRefGoogle Scholar
  24. 24.
    Department of Health & Ageing and Medication Management & Research Section. Home medicines review program qualitative research project final report. 2008 [cited 2010 15 March]; Available from:$File/HMR%20Final%20Report.pdf.
  25. 25.
    Doucette WR, Nevins J, McDonough RP. Factors affecting collaborative care between pharmacists and physicians. Res Social Adm Pharm. 2005;1(4):565–78.PubMedCrossRefGoogle Scholar
  26. 26.
    Schulz R, Johnson AC. Management of hospitals and health services: strategic issues and performance. 3rd ed. United States of America: C.V. Mosby Company; 1990.Google Scholar
  27. 27.
    Laubscher T, Evans C, Blackburn D, Taylor J, McKay S. Collaboration between family physicians and community pharmacists to enhance adherence to chronic medications: opinions of Saskatchewan family physicians. Can Fam Physician. 2009;55(12):e69.PubMedGoogle Scholar
  28. 28.
    McGrath S, Snyder ME, Duenas GG, Pringle JL. Physician perceptions of pharmacist-provided medication therapy management: qualitative analysis. J Am Pharm Assoc. 2010;50(1):67–71.CrossRefGoogle Scholar
  29. 29.
    Bradley F, Elvey R, Ashroft DM, Hassell K, Kendall J, Sibbald B, Noyce P. The challenge of intergrating community pharmacists into the primary health care team: a case study of local pharmaceutical services (LPS) pilots and interprofessional collaboration. J Interprof Care. 2008;22(4):387–98.PubMedCrossRefGoogle Scholar
  30. 30.
    Porteous T, Bond C. Evaluation of a pharmacist-managed repeat dispensing system: the GP perspective. Int J Pharm Pract. 2005;13(1):41–6.CrossRefGoogle Scholar
  31. 31.
    Farrell B. Shifts in expectations: evaluating physicians’ perceptions as pharmacists become integrated into family practice. J Interprof Care. 2010;24(1):80–9.PubMedCrossRefGoogle Scholar
  32. 32.
    Bryant L. General practitioner perceptions of clinical medication reviews undertaken by community pharmacists. Primary Health Care. 2010;2(3):225–33.Google Scholar
  33. 33.
    Chen TF. Exploring elements of interprofessional collaboration between pharmacists and physicians in medication review. Pharm World Sci. 2007;29(6):574–6.PubMedCrossRefGoogle Scholar
  34. 34.
    Rigby D. Collaboration between doctors and pharmacists in the community. Aust Prescr. 2010;33:191–3.Google Scholar
  35. 35.
    Harding G. Professional relationships between general practitioners and pharmacists in health centres. Br J Gen Pract. 1990;40(340):464.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2012

Authors and Affiliations

  • Ernieda Hatah
    • 1
    • 2
  • Rhiannon Braund
    • 1
  • Stephen Duffull
    • 1
  • June Tordoff
    • 1
  1. 1.School of PharmacyUniversity of OtagoDunedinNew Zealand
  2. 2.Faculty of PharmacyUniversiti Kebangsaan MalaysiaKuala LumpurMalaysia

Personalised recommendations